Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

How the proposed Medicare Physician Fee Schedule could impact nuclear cardiology

The American Society of Nuclear Cardiology explored some key points included in the 2025 Medicare Physician Fee Schedule proposed rule.

Medicare money payment reimbursement dollar decline george washington

Doctors sound alarm over ‘dangerous’ payment cuts in proposed Medicare Physician Fee Schedule

According to the new proposal, the 2025 conversion factor would be $32.36, down approximately 2.8% from 2024. SCAI, MGMA and other groups have already stepped forward with warnings that these cuts could do significant damage to patient care. 

Jason Wasfy, MD, associate professor at the Harvard Medical School and director of quality and outcomes research, Massachusetts General Hospital Heart Center, spoke at the Heart Rhythm Society 2024 meeting in the business of cardiology sessions about the current and future models of value based payments.

Value-based care gives cardiology practices an opportunity to thrive

Value-based payments can impact cardiology practices in many ways, helping cardiologists acquire new technology and boost patient care.

cardiologist patient heart compensation starting salary 2022 interventional cardiologist

The cardiologist shortage is here: 46% of all US counties have no heart doctors

Counties with no cardiologists tend to be “rural and socioeconomically disadvantaged,” researchers noted. The group called for policy reform and new technologies to help address the issue. 

healthcare business deal

Tracking private equity: Cardiologist, CEO share perspective on acquisition trends

The ongoing rise of private equity continues to be one of the biggest topics in modern healthcare. 

the words "FDA recall" on a board

Abbott’s HeartMate LVADs recalled again over screen issues—FDA highlights significant risks

Abbott has received multiple reports of its HeartMate monitor screens freezing, glitching and even displaying incorrect patient information. A total of 17 injuries have been reported so far. 

pharmaceutical drug approval process

Biden Administration lowers prices for 64 prescription drugs, including 3 prescribed by cardiologists

The new list of discounted drugs includes an anticoagulant, a beta-blocker used to treat atrial fibrillation and much more. 

Cardiologist heart

New editor shares vision for ACC’s flagship journal: ‘Chasing impact, not impact factor’

Veteran cardiologist Harlan M. Krumholz, MD, has a long history in medical research as both an author and an editor. He and his team want to review manuscripts quickly and publish a wide variety of voices.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Trimed Popup
Trimed Popup